Prevalence of HIV Drug Resistance Before and 1 Year After Treatment Initiation in 4 Sites in the Malawi Antiretroviral Treatment Program
- 15 May 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (suppl_4) , S362-S368
Abstract
Since 2004, the Malawi antiretroviral treatment (ART) program has provided a public health-focused system based on World Health Organization clinical staging, standardized first-line ART regimens, limited laboratory monitoring, and no patient-level monitoring of human immunodeficiency virus drug resistance (HIVDR). The Malawi Ministry of Health conducts periodic evaluations of HIVDR development in prospective cohorts at sentinel clinics. We evaluated viral load suppression, HIVDR, and factors associated with HIVDR in 4 ART sites at 12-15 months after ART initiation. More than 70% of patients initiating ART had viral suppression at 12 months. HIVDR prevalence (6.1%) after 12 months of ART was low and largely associated with baseline HIVDR. Better follow-up, removal of barriers to on-time drug pickups, and adherence education for patients 16-24 years of age may further prevent HIVDR.Keywords
This publication has 25 references indexed in Scilit:
- Early active follow‐up of patients on antiretroviral therapy (ART) who are lost to follow‐up: the ‘Back‐to‐Care’ project in Lilongwe, MalawiTropical Medicine & International Health, 2010
- Varied Patterns of HIV-1 Drug Resistance on Failing First-Line Antiretroviral Therapy in South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- High Frequency of Antiretroviral Drug Resistance among HIV‐Infected Adults Receiving First‐Line Highly Active Antiretroviral Therapy in N’Djamena, ChadClinical Infectious Diseases, 2009
- The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapyAIDS, 2009
- Viraemia and HIV-1 drug resistance mutations among patients receiving antiretroviral treatment in MozambiqueTransactions of the Royal Society of Tropical Medicine and Hygiene, 2009
- Low Levels of Antiretroviral‐Resistant HIV Infection in a Routine Clinic in Cameroon that Uses the World Health Organization (WHO) Public Health Approach to Monitor Antiretroviral Treatment and Adequacy with the WHO Recommendation for Second‐Line TreatmentClinical Infectious Diseases, 2009
- Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in UgandaAIDS, 2009
- A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth.2009
- Rapid scaling-up of antiretroviral therapy in 10 000 adults in Côte d'Ivoire: 2-year outcomes and determinantsAIDS, 2008
- World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sitesAntiviral Therapy, 2008